Welcome to our dedicated page for Lumentum Holdings SEC filings (Ticker: LITE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Lumentum Holdings's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Lumentum Holdings's regulatory disclosures and financial reporting.
Lumentum (NASDAQ:LITE) filed a Form 4 revealing director Alan S. Lowe sold 20,000 common shares on 06/26/2025 at $93.47, generating roughly $1.87 million. The trade, executed under a Rule 10b5-1 plan adopted 11/20/2024, reduced his direct stake by about 8% to 230,471 shares.
No derivative transactions were reported. While pre-scheduled, the sale size exceeds materiality thresholds and may influence investor sentiment.
Lumentum Holdings Director Alan S. Lowe has filed a Form 144 indicating intent to sell 20,000 shares of common stock with an aggregate market value of $1,869,400. The planned sale is scheduled for June 26, 2025, through Morgan Stanley Smith Barney on NASDAQ.
The shares to be sold were acquired through multiple transactions between August 2022 and February 2023, including:
- Restricted Stock grants totaling 5,824 shares
- Performance Share awards totaling 14,176 shares
Notable recent trading activity shows Lowe has sold 30,000 shares in the past three months for total gross proceeds of approximately $2.6 million. The filing indicates Lowe is trading under a 10b5-1 plan adopted on November 20, 2024, and affirms no knowledge of undisclosed material adverse information regarding Lumentum's operations.
Director Alan S. Lowe of Lumentum Holdings has reported a significant insider transaction, selling 20,000 shares of Common Stock at $88.47 per share on June 18, 2025. The transaction was executed under a Rule 10b5-1 trading plan established on November 20, 2024.
Following the sale, Lowe maintains direct ownership of 250,471 shares of Lumentum Holdings. The transaction was reported via Form 4 filing, with attorney Jae Kim signing as the authorized representative on June 20, 2025.
- Transaction value: Approximately $1.77 million
- Trading plan: Executed under pre-established Rule 10b5-1 plan
- Position: Director (Non-executive board member)
- Ownership: Direct beneficial ownership
Lumentum Holdings Form 144 filing details a proposed sale of securities by an insider. The filing indicates plans to sell 20,000 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $1,769,400.
The securities to be sold were acquired through two transactions:
- 8,280 shares as Restricted Stock on August 31, 2022
- 11,720 shares as Performance Shares on August 22, 2022
Recent trading activity by the seller (Alan S. Lowe) in the past 3 months includes three sales on June 4, 2025, totaling 10,000 shares with combined gross proceeds of $835,800. The sale will be executed on the NASDAQ, with an approximate sale date of June 18, 2025. The company currently has approximately 69.4 million shares outstanding.